Zealand Pharma AS (CHIX:ZEALC) FCF Yield % : -2.48 (As of Mar. 27, 2025)

View and export this data going back to 2013. Start your Free Trial

What is Zealand Pharma AS FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Zealand Pharma AS's Trailing 12-Month Free Cash Flow is kr-943.96 Mil, and Market Cap is kr38,059.99 Mil. Therefore, Zealand Pharma AS's FCF Yield % for today is -2.48%.

The historical rank and industry rank for Zealand Pharma AS's FCF Yield % or its related term are showing as below:

CHIX:ZEALc' s FCF Yield % Range Over the Past 10 Years
Min: -37.12 Med: -6.8 Max: 1.41
Current: -2.48

During the past 13 years, the highest FCF Yield % of Zealand Pharma AS was 1.41%. The lowest was -37.12%. And the median was -6.80%.

CHIX:ZEALc's FCF Yield % is ranked better than
75.6% of 1500 companies
in the Biotechnology industry
Industry Median: -14.58 vs CHIX:ZEALc: -2.48

Zealand Pharma AS's FCF Margin % for the quarter that ended in Dec. 2024 was -2,025.95%.

Zealand Pharma AS FCF Yield % Historical Data

The historical data trend for Zealand Pharma AS's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma AS FCF Yield % Chart

Zealand Pharma AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-8.09

-18.76

-9.14

-2.13

-1.67

Zealand Pharma AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															0.93	-2.13	-1.75	-2.01	-1.30

Competitive Comparison of Zealand Pharma AS's FCF Yield %

For the Biotechnology subindustry, Zealand Pharma AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zealand Pharma AS's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zealand Pharma AS's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Zealand Pharma AS's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Zealand Pharma AS FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Zealand Pharma AS's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-943.964	/	56643.6375
	=	-1.67%

Zealand Pharma AS's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-183.47	*	4	/	56643.6375
	=	-1.30%

Zealand Pharma AS FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Zealand Pharma AS FCF Yield % Related Terms

Thank you for viewing the detailed overview of Zealand Pharma AS's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zealand Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma AS (CHIX:ZEALc) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ZLDPF:USA 0NZU:UK ZEAL:Denmark 22Z:Germany

Address

Sydmarken 11, Soborg, DNK, DK-2860

Website

https://www.zealandpharma.com

Zealand Pharma AS is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.

Zealand Pharma AS Headlines

No Headlines